A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT02632721 · COMPLETED
Trial details
- NCT number
- NCT02632721
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-16
- Primary completion
- 2023-01-16
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.